Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0AI7H
|
|||
| Drug Name |
Anti-MUC1 CAR T Cells
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | Lung cancer [ICD-11: 2C25.0] | Phase 1/2 | [1] | |
| Non-small-cell lung cancer [ICD-11: 2C25.Y; ICD-9: 162] | Phase 1/2 | [1] | ||
| Company |
The First Affiliated Hospital of Guangdong Pharmaceutical University
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Mucin-1 (MUC1) | Target Info | CAR-T-Cell-Therapy | [1] |
| WikiPathways | Hematopoietic Stem Cell Differentiation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03525782) Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.